DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Neuronal SignalingNeuronal Signaling
  5. /SecretaseSecretase
  6. /LY3202626LY3202626
Chemical structure of CAS 1628690-73-2

LY3202626

CAS No.1628690-73-2
MDL No.N/A
MFC22H20F2N8O2S
MW498.50
InChI KeyVQSRKMNBWMHJKY-YTEVENLXSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1628690-73-2
Product NameLY3202626
Heavy Atom Count35Rotatable Bond Count5
Atom Stereo Count2Bond Stereo Count0
HBA10HBD2
TPSA131.510 ŲCharge0
Exact Mass498.13980Complexity1291.62
pKa7.130XLogP2.199

Related Articles

Studies related to this compound and its mechanism of action

Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor.

Journal of medicinal chemistry • Vol. 64, Issue 12 • 2021
PMID: 34081466DOI: 10.1021/acs.jmedchem.1c00489

Documentation

Similar Products

  • Elenbecestat

    CAS No.1388651-30-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact